atazanavir sulfate has been researched along with HIV-Associated Lipodystrophy Syndrome in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (73.33) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guaraldi, G; Santoro, A; Stentarelli, C; Zona, S | 1 |
| Martínez Chamorro, E | 1 |
| Antela López, A | 1 |
| Curto, J; del Rio, L; Domingo, P; Ferrer, E; Gatell, JM; Martínez, E; Negredo, E; Ordóñez, J; Podzamczer, D; Ribera, E; Rosales, J; Saumoy, M | 1 |
| Carnevale, G; Cavallini, GM; Cossarizza, A; De Biasi, S; De Pol, A; Gibellini, L; Mussini, C; Nasi, M; O'Connor, JE; Pinti, M; Riccio, M; Sala de Oyanguren, FJ | 1 |
| Collier, AC; Daar, ES; Fichtenbaum, CJ; Fink, H; Gerschenson, M; Kosmiski, L; Libutti, DE; McComsey, GA; O'Riordan, M; Santana, JL; Sax, PE | 1 |
| Murphy, RL | 1 |
| Haerter, G; Kern, P; Manfras, BJ; Mueller, M; Trein, A | 1 |
| Gazzard, BG; Moyle, G | 1 |
| Acinapura, R; Antinori, A; Liuzzi, G; Marconi, P; Sette, P; Trotta, MP; Zaccarelli, M; Zinzi, D | 1 |
| Adams-Huet, B; Boonyavarakul, A; Dinges, W; Garg, A; Jacob, K; Peterson, D; Quittner, C; Shah, M; Tierney, K | 1 |
| Dellamonica, P | 1 |
| Scott, LJ; Swainston Harrison, T | 1 |
| Arathoon, E; Arlotti, M; Giordano, M; Jemsek, JG; Noor, MA; Perez, C; Pokrovskiy, V; Soccodato, M; Sosa, N; Thiry, A | 1 |
6 review(s) available for atazanavir sulfate and HIV-Associated Lipodystrophy Syndrome
| Article | Year |
|---|---|
HIV-associated lipodystrophy: impact of antiretroviral therapy.
Topics: Adiposity; Aging; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Darunavir; Drug Combinations; HIV Infections; HIV Integrase Inhibitors; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Nucleosides; Oligopeptides; Pyridines; Pyrrolidinones; Raltegravir Potassium; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Sulfonamides | 2013 |
[Lipid profile of atazanavir].
Topics: Adipocytes; Anti-HIV Agents; Atazanavir Sulfate; Cardiovascular Diseases; Cells, Cultured; Cholesterol; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combination; Dyslipidemias; Glucose; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Multicenter Studies as Topic; Oligopeptides; Pyridines; Risk Factors; Salvage Therapy; Triglycerides | 2008 |
[Utility of atazanavir in special populations].
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Cardiovascular Diseases; Child; Child, Preschool; Clinical Trials as Topic; Drug Interactions; Drug Therapy, Combination; Emigrants and Immigrants; Female; Heroin Dependence; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Hyperbilirubinemia, Neonatal; Infant; Infant, Newborn; Insulin Resistance; Kidney Diseases; Liver Diseases; Male; Methadone; Multicenter Studies as Topic; Oligopeptides; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Pyridines; Young Adult | 2008 |
Reviving protease inhibitors: new data and more options.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Carbamates; Clinical Trials as Topic; Furans; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Oligopeptides; Organophosphates; Pyridines; Pyrones; Sulfonamides | 2003 |
Does atazanavir cause lipodystrophy?
Topics: Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Oligopeptides; Pyridines | 2004 |
Atazanavir: a review of its use in the management of HIV infection.
Topics: Anti-HIV Agents; Area Under Curve; Atazanavir Sulfate; Drug Interactions; Drug Resistance, Viral; Drug Therapy, Combination; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Hyperlipidemias; In Vitro Techniques; Insulin Resistance; Oligopeptides; Protease Inhibitors; Pyridines | 2005 |
2 trial(s) available for atazanavir sulfate and HIV-Associated Lipodystrophy Syndrome
| Article | Year |
|---|---|
Changes in fat mitochondrial DNA and function in subjects randomized to abacavir-lamivudine or tenofovir DF-emtricitabine with atazanavir-ritonavir or efavirenz: AIDS Clinical Trials Group study A5224s, substudy of A5202.
Topics: Adenine; Adipose Tissue; Adult; Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Deoxycytidine; Dideoxynucleosides; DNA, Mitochondrial; Drug Combinations; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Male; Mitochondria; Oligopeptides; Organophosphonates; Pyridines; Reverse Transcriptase Inhibitors; Ritonavir; Tenofovir; Treatment Outcome | 2013 |
Body fat and other metabolic effects of atazanavir and efavirenz, each administered in combination with zidovudine plus lamivudine, in antiretroviral-naive HIV-infected patients.
Topics: Adiposity; Adult; Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Male; Oligopeptides; Oxazines; Pyridines; Zidovudine | 2006 |
7 other study(ies) available for atazanavir sulfate and HIV-Associated Lipodystrophy Syndrome
| Article | Year |
|---|---|
Impact of switching from lopinavir/ritonavir to atazanavir/ritonavir on body fat redistribution in virologically suppressed HIV-infected adults.
Topics: Absorptiometry, Photon; Adipose Tissue; Adult; Aged; Anti-HIV Agents; Atazanavir Sulfate; Body Fat Distribution; Body Mass Index; Female; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Lopinavir; Male; Middle Aged; Oligopeptides; Prospective Studies; Pyridines; Ritonavir; Young Adult | 2011 |
The protease inhibitor atazanavir triggers autophagy and mitophagy in human preadipocytes.
Topics: Adipocytes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Autophagy; Blotting, Western; Cells, Cultured; Dose-Response Relationship, Drug; Female; Flow Cytometry; Green Fluorescent Proteins; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Microscopy, Electron; Mitophagy; Oligopeptides; Pyridines | 2012 |
Regression of lipodystrophy in HIV-infected patients under therapy with the new protease inhibitor atazanavir.
Topics: Adult; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Female; HIV Protease Inhibitors; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Middle Aged; Oligopeptides; Pyridines | 2004 |
[Long-term tolerance. Favorable lipid profile--favorable effect on development of lipodystrophy?].
Topics: Adult; Atazanavir Sulfate; Cardiovascular Diseases; Clinical Trials as Topic; Delayed-Action Preparations; HIV Infections; HIV Protease Inhibitors; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Insulin Resistance; Lipids; Long-Term Care; Oligopeptides; Pyridines | 2004 |
Lipodystrophy is associated with a low rate of treatment failure in HIV-positive patients switched to atazanavir.
Topics: Atazanavir Sulfate; HIV Seropositivity; HIV-Associated Lipodystrophy Syndrome; Humans; Oligopeptides; Pyridines; Switzerland; Treatment Failure; Treatment Refusal | 2005 |
The role of diet, exercise and smoking in dyslipidaemia in HIV-infected patients with lipodystrophy.
Topics: Adult; Atazanavir Sulfate; Cholesterol; Diet; Dietary Fiber; Dietary Proteins; Dyslipidemias; Exercise; Female; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Middle Aged; Oligopeptides; Protease Inhibitors; Pyridines; Smoking; Trans Fatty Acids; Triglycerides | 2005 |
Can boosted atazanavir induce hyperlipotrophy?
Topics: Aged; Atazanavir Sulfate; Bilirubin; Female; Hepatitis C; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Oligopeptides; Protease Inhibitors; Pyridines | 2006 |